Simulations Plus SLP Clinical Operations — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Simulations Plus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Simulations Plus's clinical operations — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Simulations Plus's clinical operations — revenue?
- Simulations Plus (SLP) reported clinical operations — revenue of $415K in Q4 2025.
- What does clinical operations — revenue mean?
- This metric represents the total gross revenue generated from clinical operations, consulting, and contract research services provided to the pharmaceutical and biotechnology industries. It tracks the financial performance of the service-based segment, reflecting the company's ability to monetize its expertise in drug development and clinical trial support. Monitoring this revenue stream helps investors assess the scale and growth trajectory of the company's service-oriented business model.